PMID- 30836075 OWN - NLM STAT- MEDLINE DCOM- 20200807 LR - 20200807 IS - 1531-5053 (Electronic) IS - 0278-2391 (Linking) VI - 77 IP - 8 DP - 2019 Aug TI - Discrepancies in Interpretation of the Minor Salivary Gland Biopsy in the Diagnosis of Sjogren Syndrome. PG - 1628-1635 LID - S0278-2391(19)30127-2 [pii] LID - 10.1016/j.joms.2019.01.052 [doi] AB - PURPOSE: Although the minor salivary gland biopsy (MSGB) is a major criterion for the diagnosis of Sjogren syndrome (SS), multiple studies have outlined difficulties in standardization. The purpose of this study was to answer the following question: in all patients referred for MSGB, did strict application of focus scoring criteria alter the sensitivity of and predictive value of the MSGB in the diagnosis of SS compared with the initial interpretation? MATERIALS AND METHODS: The authors designed a cross-sectional study of patients referred to the Massachusetts General Hospital Department of Oral and Maxillofacial Surgery (Boston, MA) over a 5-year period for MSGB. The primary predictor variable was the MSGB focus score. The primary outcome variable was the SS diagnosis. The newly established SS diagnosis status results were compared with the initial SS diagnoses. Sensitivity, specificity, and positive and negative predictive values (PPV and NPV) were calculated. Other relevant variables of interest, such as size of glandular tissue harvested and associated signs and symptoms, also were documented. The primary predictor variable was the MSGB focus score and the primary outcome variable was the SS diagnosis (positive or negative). RESULTS: Seventy-three patients met the inclusion criteria. The mean age was 48.5 years (range, 19 to 71 yr) and 64 were women (87.6%). The authors' previous study using initial pathology reports yielded 80.0% sensitivity, 87.5% specificity, 57.1% PPV, and 95.5% NPV. The present review of the MSGB using strict focus scoring guidelines yielded 95.4% sensitivity, 76.4% specificity, 63.6% PPV, and 97.5% NPV. CONCLUSIONS: The MSGB is an important major criterion in establishing a diagnosis of SS. Application of strict focus scoring guidelines when reviewing the MSGB yielded a sensitivity far greater than initially reported in this group. Difficulties with interpretation are discussed. Future studies will focus on improvement of interpretation and immunohistochemical aids in diagnosis. CI - Copyright (c) 2019 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved. FAU - Wicheta, Sarah AU - Wicheta S AD - Predoctoral Student, Harvard School of Dental Medicine, Boston, MA. FAU - Van der Groen, Troy AU - Van der Groen T AD - Resident, Portsmouth Naval Medical Center, Portsmouth, VA and Harvard School of Dental Medicine, Boston, MA. FAU - Faquin, William C AU - Faquin WC AD - Professor, Department of Head and Neck Pathology and Cytology, Massachusetts General Hospital, Boston, MA. FAU - August, Meredith AU - August M AD - Associate Professor, Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: maugust@partners.org. LA - eng PT - Journal Article PT - Review DEP - 20190208 PL - United States TA - J Oral Maxillofac Surg JT - Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons JID - 8206428 SB - IM MH - Adult MH - Aged MH - Biopsy MH - Cross-Sectional Studies MH - Female MH - Humans MH - Middle Aged MH - *Salivary Glands, Minor/pathology MH - *Sjogren's Syndrome/diagnosis MH - Young Adult EDAT- 2019/03/06 06:00 MHDA- 2020/08/08 06:00 CRDT- 2019/03/06 06:00 PHST- 2018/11/07 00:00 [received] PHST- 2019/01/31 00:00 [revised] PHST- 2019/01/31 00:00 [accepted] PHST- 2019/03/06 06:00 [pubmed] PHST- 2020/08/08 06:00 [medline] PHST- 2019/03/06 06:00 [entrez] AID - S0278-2391(19)30127-2 [pii] AID - 10.1016/j.joms.2019.01.052 [doi] PST - ppublish SO - J Oral Maxillofac Surg. 2019 Aug;77(8):1628-1635. doi: 10.1016/j.joms.2019.01.052. Epub 2019 Feb 8.